Danco Seeks Supreme Court Stay Of Ruling That Pauses Mail-Order Access To Abortion Drugs
Government
The Supreme Court in 2024 took up a challenge to the mail-order rule by medical groups and doctors, but ruled that they lacked legal standing to sue. May 2 (Reuters) - Pharmaceutical company Danco Laboratories filed an application with the U.S. Supreme Court on Saturday seeking a stay of an appeals court ruling that temporarily blocks the abortion drug mifepristone from being dispensed through the mail. The appeals court ruling was issued unanimously by a conservative three-judge panel on
din zilele anterioare